A Belfast biotech company has raised £900,000 to help develop new drug products using its AI discovery platform.
AMPLY Discovery, a spinout from Queens University Belfast, focuses on helping solve the challenges posed by antimicrobial resistance which can render antibiotics ineffective against bacteria, viruses and fungi. It is using AI and machine-learning techniques to discover new anti-infective products and is currently developing an anti-infective product to tackle bovine mastitis, for which it has received funding from Innovate UK.
Established 2021 by researchers in the School of Biological Science at Queen’s AMPLY Discovery’s technology platform has been the subject of more than eight years of scientific research.
